Piermont Capital Management’s Nektar Therapeutics NKTR Stock Holding History

Piermont Capital Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell
2018 Q2	$223K	Buy
2017 Q4	–	Sell
2017 Q3	$554K	Sell
2017 Q2	$895K	Buy
2016 Q4	–	Sell
2016 Q3	$534K	Sell
2016 Q2	$855K	Buy
2016 Q1	$425K	Buy